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Letter 
Atopic eczema (AE) is a heterogeneous chronic inflammatory skin condition that affects 
approximately 15-20% of children worldwide (Nutten, 2015). The prevalence varies widely 
among different countries, between rural and urban areas within a single country and 
particular Asian skin types are more sensitive to urban environments (Krutmann et al., 2014, 
Ben-Gashir et al., 2004, Nutten, 2015, Odhiambo et al., 2009). In this study, we analyzed the 
genetic architecture of AE patients from the South Asian Bangladeshi community in East 
London (UK) using Whole Exome Sequencing (WES) combined with rare variant enrichment 
analysis. A total of 70 Bangladeshi Sylheti families each with at least two affected siblings 
presenting with severe AE (determined by National Institute for Health and Care Excellence 
(NICE) guidelines) were recruited via the pediatric dermatology clinic at the Royal London 
Hospital, London (UK). The majority of the affected individuals were born in the UK and 
also presented with very high IgE levels and other atopic phenotypes, such as food allergy, 
asthma and hay fever.  
Genomic DNA was extracted from EDTA-peripheral blood samples from family 
members after written informed consent and in adherence with the Declaration of Helsinki 
Principles and approval from the East London and City Health Authority. WES was 
performed in 43 probands of 42 Bangladeshi families and an enrichment analysis was 
performed towards identifying possible AE associated rare coding gene variants. Exome 
capture and enrichment was performed using various versions of the Agilent capture platform. 
The subsequent DNA library was sequenced with 100 bp paired-end reads on the HiSeq 2000 
platform (Illumina). Resulting sequence data were aligned to the hg19 human reference 
genome using the Novoalign alignment tool (Novocraft Technologies Sdn Bhd). Sequence 
variants were called with SAMtools and annotated with ANNOVAR (Wang et al., 2010). 
Variants were filtered for novelty by comparison to ExAC, in-house exomes, dbSNP137 and 
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1000 genomes. The association analysis is based on the hypothesis, that multiple rare variants 
can contribute to the genetic susceptibility to common diseases (Schork et al., 2009). We 
sought to establish the presence of an excess of rare dominant (<1%) and low frequency 
recessive (<5%) missense, frameshift, and nonsense variants between 43 probands and 232 
ethnically matched unrelated control samples, association was assessed using a simple 
Fisher’s exact test. 
This analysis revealed that filaggrin (FLG) harbored the highest number of enriched 
dominant (Odds ratio = 12.1, P < 0.0001) and recessive loss-of-function, i.e. nonsense and 
frameshift mutations (Odds ratio = 43.4, P < 0.0001) (Table 1). FLG missense variants were 
not enriched in the Bangladeshi probands. In total, 13 loss-of-function FLG variants, of which 
five were unreported variants, were identified in 21 of the 43 Bangladeshi probands using 
WES (Figure 1a, Supplementary Table S1). Moreover, the presence of numerous FLG loss-
of-function mutations among the Bangladeshi probands, prompted us to sequence further 
affected family members (n=42) and probands (n=34) from 28 additional Bangladeshi 
families using a targeted array-based resequencing assay for FLG (Wong et al., 2017). All 
FLG loss-of-function variants were validated using Sanger sequencing and tested for 
segregation in all available family members. This revealed five additional variants in 33 
probands, of which three were previously unreported mutations: c.2767insT (p.S923Ffs*2), 
c.4630delA (p.T1545Qfs*163), and c.7055C>G (p.S2352*) (Figure 1a, Supplementary 
Table S1). Furthermore, these genetic data revealed intrafamilial heterogeneity with multiple 
FLG variants often segregating within the Bangladeshi AE families (Figure 1b, 
Supplementary Table S1).  
In addition, this rare variant association testing led to the identification of a potential 
burden of risk variants in as yet unreported AE associated gene loci, including ADCY10, 
CUX2, MAST2, MCM10, MTF1, ORM2, PANX3, PHLDB1, SCAND3, TCHHL1 (Table 1, 
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Supplementary Table S2). The rare sequence variation of top 10 candidate genes in exome 
data from other AE cohorts with European, African-American, and Singapore Chinese 
ancestry was also analysed using allele frequencies of population-specific control exome data 
from the ExAC genome browser (accessed September 13-17, 2017; 
http://exac.broadinstitute.org/) (Figure 1c, Supplementary Tables S3 and S4). Allele 
frequencies were analyzed descriptively. 
The comparison of the rare risk variants in AE compared to the ExAC data showed 
that the Bangladeshi AE-associated risk loci were, in part, also identified in the additional 
populations, with some AE risk variants shared between populations, e.g. ADCY10, CUX2, 
MAST2, ORM2, while others maybe ethnicity-specific, e.g. MTF1, PANX3, TCHHL1 (Figure 
1c, Supplementary Tables S3 and S4). Preliminary data showed that MTF1, ORM2 and 
TCHHL1 also appear to be replicated in Irish AE exomes (Supplementary Tables S3 and 
S4).  
This rare variant enrichment strategy demonstrated that FLG represents the major AE 
risk gene in the Bangladeshi population with approximately 50% of AE affected individuals 
carrying one or more FLG loss-of-function variant. In contrast to FLG, whose role in the 
epidermis has been characterized in much detail, the precise function of the other AE gene 
variants is, at present, not defined (Supplementary Table S2). We postulate that rare coding 
variants particularly MTF1 (a metal-regulatory transcription factor that regulates expression 
of, for example, cadmium and zinc) (Gunther et al., 2012, Kimura and Kambe, 2016), and 
ORM2 (a regulator of sphingolipid homeostasis) (Gururaj et al., 2013) could play a significant 
role in AE disease expression, regulation of immune responses, and/or environmental sensing.  
This study has revealed insights into the genetic landscape of AE and adds to our 
multiethnic understanding of AE. Rare putative loss of function alleles in FLG was identified 
as a major component of disease susceptibility in the Bangladeshi AE cohort, however, the 
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burden analysis also identified a series of putative AE risk loci. Whilst the scope of 
replication was limited, additional evidence for the role of some of these genes in AE was 
also observed in three cohorts of individuals with AE from distinct ethnic ancestries.  
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Figure 1: Filaggrin (FLG) risk variants identified in the Bangladeshi atopic eczema (AE) 
cohort and putative risk genes.  
(a) Schematic representation of FLG showing all loss-of-function variants identified in this 
study. (Red arrows indicate previously unreported variants, variants shown black and gray 
were identified using whole exome sequencing or targeted re-sequencing, respectively) (b) 
Exome and targeted resequencing demonstrated an intrafamilial heterogeneity of FLG risk 
variants in the Bangladeshi AE cohort, segregating, in part, within families. Of note, the 
parents and the oldest sibling (all unaffected) of both families were born in Bangladesh. All 
other siblings were born in the UK. (Black symbols indicate affected individuals, gray circle 
indicates a previously affected daughter, white symbols represent unaffected individuals) (c) 
Heat Maps showing the number of rare variants identified in the different AE cohorts from 
this study. Data are based on allele frequencies from ethnically-matching subpopulations 
obtained from the genomic database ExAC. Recessive and dominant variants were considered 
rare if they had an allele frequency <0.05 and <0.01, respectively. Filaggrin (FLG) loss-of-
function variants were excluded in the African-American cohort as described previously 
(Margolis et al., 2014).  
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GENE/ 
GENE NAME 
MUTATION 
TYPE 
CHROMO-
SOME 
ODDS 
RATIO P-VALUE 
FLG/ 
Filaggrin 
recessive frameshift 
or nonsense 
1 
(152276443-
152286591) 
43.4 
< 0.0001 dominant frameshift 
or nonsense 
12.1 
SCAND3 (ZBED9)/ 
SCAN Domain 
Containing Protein 3 
(Zinc Finger BED-
Type Containing 9) 
dominant missense 
6 
(28542927-
28554107) 
30.8 0.0002 
TCHHL1/  
Trichohyalin Like 1 recessive missense 
1 
(152057583-
152060564) 
25.0 0.0008 
ADCY10/  
Adenylate Cyclase 10 
dominant frameshift 
or nonsense 
1 
(167778964-
167871251) 
19.5 0.0041 
MTF1/ 
Metal Regulatory 
Transcription Factor 1 
dominant missense 
1 
(38280953-
38323065) 
7.6 0.0030 
MCM10/ 
 Minichromosome 
Maintenance 10 
Replication Initiation 
Factor 
dominant missense 
10 
(13213067-
13251266) 
6.2 0.0004 
ORM2/  
Orosomucoid 2 dominant missense 
9 
(117092297-
117094168) 
6.1 0.0015 
CUX2/ 
Cut Like Homeobox 2 dominant missense 
12 
(111729278-
111786109) 
5.3 0.0026 
MAST2/  
Microtubule 
Associated 
Serine/Threonine 
Kinase 2 
dominant missense 
1 
(46463419-
46501578) 
4.9 0.0021 
PHLDB1/  
Pleckstrin Homology 
Like Domain Family 
B Member 1 
recessive missense 
11 
(118485376-
118520801) 
4.5 0.0082 
PANX3/ 
Pannexin 3 dominant missense 
11 
(124487339-
124489689) 
infinity 0.0002 
Table 1: Exome sequencing and subsequent enrichment of rare variants led to the 
identification of risk genes linked to atopic eczema 
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